about
An unusual case of acute respiratory failure in a patient with pulmonary veins stenosis late after catheter ablation of atrial fibrillation: a case report and the review of the literatureAssociation of intraventricular mechanical dyssynchrony with response to cardiac resynchronization therapy in heart failure patients with a narrow QRS complex.Actual pacemaker longevity: the benefit of stimulation by automatic capture verification.Long-term follow-up of patients with syncope evaluated by head-up tilt test.Effect of cardiac resynchronization therapy in patients without left intraventricular dyssynchrony.Telecardiology and remote monitoring of implanted electrical devices: the potential for fresh clinical care perspectivesCardiac resynchronization therapy in clinical practice: need for electrical, mechanical, clinical and logistic synchronization.How, why, and when may atrial defibrillation find a specific role in implantable devices? A clinical viewpoint.Potential of non-antiarrhythmic drugs to provide an innovative upstream approach to the pharmacological prevention of sudden cardiac death.Expenditure and value for money: the challenge of implantable cardioverter defibrillators.Role of left ventricular twist mechanics in the assessment of cardiac dyssynchrony in heart failure.Role of drugs and devices in patients at risk of sudden cardiac death.Morbidity and mortality in heart failure patients treated with cardiac resynchronization therapy: influence of pre-implantation characteristics on long-term outcome.Multimodality imaging in diabetic heart disease.Emerging role of multimodality imaging to evaluate patients at risk for sudden cardiac death.Remote monitoring of implantable devices: Should we continue to ignore it?An update on atrial fibrillation in 2014: From pathophysiology to treatment.How to truly value implantable cardioverter-defibrillators technology: up-front cost or daily cost?Mitral valve morphology assessment: three-dimensional transesophageal echocardiography versus computed tomography.Incremental prognostic value of novel left ventricular diastolic indexes for prediction of clinical outcome in patients with ST-elevation myocardial infarction.Left Ventricular Reverse Remodeling Elicited by a Quadripolar Lead: Results from the Multicenter Per4mer Study.Frequency of "Pocket" Hematoma in Patients Receiving Vitamin K Antagonist and Antiplatelet Therapy at the Time of Pacemaker or Cardioverter Defibrillator Implantation (from the POCKET Study).Anaemia in patients with aortic stenosis: influence on long-term prognosis.Predictors of nonsimultaneous interventricular delay at cardiac resynchronization therapy optimization.Myocardial steatosis and biventricular strain and strain rate imaging in patients with type 2 diabetes mellitus.Incremental value of 2-dimensional speckle tracking strain imaging to wall motion analysis for detection of coronary artery disease in patients undergoing dobutamine stress echocardiography.Viability assessment with global left ventricular longitudinal strain predicts recovery of left ventricular function after acute myocardial infarction.Predictors of death and occurrence of appropriate implantable defibrillator therapies in patients with ischemic cardiomyopathy.Radionuclide angiographic determination of regional left ventricular systolic function during rest and exercise in patients with nonischemic cardiomyopathy treated with cardiac resynchronization therapy.Global longitudinal strain predicts long-term survival in patients with chronic ischemic cardiomyopathy.Left ventricular lead stabilization to retain cardiac resynchronization therapy at long term: when is it advisable?Long-term RV threshold behavior by automated measurements: safety is the standpoint of pacemaker longevity!Noninvasive estimation of left ventricular filling pressures in patients with heart failure after surgical ventricular restoration and restrictive mitral annuloplasty.Interventricular delay interval optimization in cardiac resynchronization therapy guided by echocardiography versus guided by electrocardiographic QRS interval width.Longevity of implantable cardioverter-defibrillators: implications for clinical practice and health care systems.Impact of left atrial fibrosis and left atrial size on the outcome of catheter ablation for atrial fibrillation.How to assess the efficacy of catheter ablation of atrial fibrillation?Left ventricular versus biventricular pacing: a randomized comparative study evaluating mid-term electromechanical and clinical effects.Automatic verification of ventricular stimulation: fusion management algorithm.Troponin I rise after pacemaker implantation at the time of "universal definition of myocardial infarction".
P50
Q26779375-EFEDCF34-8A0F-4717-8415-A2175BF18348Q30478105-B27A16D4-B9F9-4699-A349-C9D04D6CC374Q33158478-BD75CE36-BBCD-4518-B045-22650FC3C769Q33158822-3C98C0FF-0C44-4F38-86A4-FEFD66CEE165Q35937766-330227B1-9670-43DD-B2CF-4D7D262D44D2Q36293555-4B44DADA-6D8F-45FD-8B41-13D4EC2DBD83Q36745486-F4A4C24D-CF7C-46FC-8B12-324B42E72CACQ36762559-9C22155F-1AE5-4381-A215-886F9A6FB07BQ36802605-EA28F434-B698-4C87-9E85-2486C51DBF3EQ37411838-E41F0113-96D3-4784-93C9-112058D11305Q37677211-16BECB09-780A-48F2-AA63-2C8518023A0BQ37770595-0AAC5009-F44C-4F1E-88BD-83A1E1CC5D44Q37778676-847F4C1E-17F1-43E8-A650-A1ABFDF69006Q37819366-D59575AD-03D8-40B7-A9DB-FC1E49209945Q38027480-D8F25CF5-E822-4315-8D71-E8282DAF56D1Q38412084-BA1A49F5-9A03-46CD-9A53-B70AD58766AFQ38613548-8EFEE1A3-E37C-447D-AE01-0B30335551ABQ39728782-4D9F6CEC-3DE2-46E8-9502-3FB959E29AE0Q39814762-F2A10E33-0B45-4383-B116-9BE281FC9760Q39897399-FF560CD4-8006-472D-9478-2F3E5FE32B59Q40236101-AC8B4519-CD73-43DA-8184-F78EEA0DD2FEQ40348341-3DF70124-EBB3-4A47-9EDC-E8624824CAF7Q40868709-533C72BB-7009-4534-BC02-4AC7F7A8B539Q41732830-7FCAD926-61A1-4269-BB4C-713881642866Q42787147-87B4CC5C-D1F0-4271-B548-C1634A58B9E8Q43255735-5910700B-3376-45AB-BB5B-83C037563850Q43263726-D8127179-F28B-4A7B-8D8C-E80A9C377085Q43408219-B8FBD51B-C467-4BCE-A066-6AC9AA525330Q43968618-FA065986-2B01-4DCD-B7F5-094A23FD2033Q44813283-34321AC3-A1A1-4ADE-ADBF-C58CF4541563Q45333498-D880B671-730B-44C9-901C-9DF3137EF647Q45815352-A4DD2D4C-F043-42F7-B881-728587BE990BQ46767278-63387FDB-9113-490F-829C-C62EA25C845EQ47245973-E8ADABC5-4F46-4BAD-BDB4-6259149A6A7EQ47364003-C63AF9B1-20FD-4A87-8732-B6BA0FD7828DQ47389029-32D9717B-6AB2-463A-9DEF-C2E994C26D32Q47598272-BE47E2A3-12D6-4373-859D-B5EC49EF0F42Q47917914-92A343E7-69E9-45AE-92AD-E93B1FCA72E0Q47986344-DBDE0DE0-DA85-46D2-B318-9E5BB592F1CDQ48019816-39C44D4B-E9EE-4F37-8D40-D9F3930DF63E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
ricercatore
@it
հետազոտող
@hy
name
Matteo Bertini
@ast
Matteo Bertini
@en
Matteo Bertini
@es
Matteo Bertini
@it
Matteo Bertini
@nl
Matteo Bertini
@sl
type
label
Matteo Bertini
@ast
Matteo Bertini
@en
Matteo Bertini
@es
Matteo Bertini
@it
Matteo Bertini
@nl
Matteo Bertini
@sl
prefLabel
Matteo Bertini
@ast
Matteo Bertini
@en
Matteo Bertini
@es
Matteo Bertini
@it
Matteo Bertini
@nl
Matteo Bertini
@sl
P106
P1153
22033600300
P21
P214
112147266966935482646
P31
P496
0000-0002-5285-7140
P734
P735
P7859
viaf-112147266966935482646